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Background: The purpose of this paper is to study the etiology, clinical findings, and outcomes of management of
cases of orbital cellulitis treated in Minia University Hospital in Upper Egypt over the period of 6 years from July
2009 to July 2015. One-hundred two patients diagnosed to have orbital cellulitis were admitted to the hospital and
treated on inpatient basis from July 2009 to July 2015. All patients were subjected to full ophthalmological
examination, systemic evaluation, and ear, nose, and throat (ENT) consultation. Axial and coronal CT scan and
orbital echography were done for all patients. All patients received medical treatments, and 20 patients
needed surgical intervention.
Results: The source of infection was paranasal sinusitis in 66 patients, trauma in 14 cases, panophthalmitis in
6 patients, and dental infection in 2 cases, and no definite source was detected in 14 cases. Subperiosteal
abscess (SPA) developed in 16 patients. The final best corrected visual acuity improved in 58% of the cases,
decreased in 4%, and remained unchanged in 38% of cases. No intracranial complication was recorded.
Conclusions: Good presenting visual acuity and appropriate medical treatment together with early surgical
intervention in cases of SPA are important factors to achieve favorable outcomes in orbital cellulitis. All cases
with SPA had paranasal sinusitis, and contrary to previous studies, superior SPA location was the most
common followed by the medial location.
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Orbital cellulitis is a serious and sight-threatening condi-
tion caused by invasive infection of the postseptal tissues
of the orbit [1]. The most common predisposing factor
for orbital cellulitis is paranasal sinus disease. Infection
may also arise from eyelids, face, retained orbital foreign
bodies, or hematogenous spread from distant sources.
Less common causes include dacryocystitis, dental infec-
tion, panophthalmitis, infected tumor, and mucormyco-
sis [2, 3]. The most common causative organisms
include Streptococcus pneumoniae, Moraxella catarrhalis,
Haemophilus species, Staphylococcus aureus, group A
streptococcus, and upper respiratory tract anaerobes [4].
Orbital cellulitis has been associated with serious* Correspondence: raafat.abdelrahman@mu.edu.eg
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the Creative Commons license, and indicate ifcomplications including visual loss, cavernous sinus
thrombosis, meningitis, frontal abscess, osteomyelitis, and
even death [2, 3]. The mechanisms of visual loss may in-
volve optic neuritis as a reaction to adjacent or nearby in-
fection, ischemia resulting from thrombophlebitis
along the valveless orbital veins, or compressive
ischemia possibly resulting in central retinal artery
occlusion [5]. Subperiosteal abscess (SPA) may result
from the accumulation of pus between the orbital
bones and periorbita [6]. Cavernous sinus thrombosis
represents the most severe complication of orbital
cellulitis and is suspected by bilateral involvement
with ophthalmoplegia and loss of vision [7]. Broad-
spectrum intravenous (IV) antibiotics that cover most
gram-positive and gram-negative bacteria should be
started once the diagnosis of orbital cellulitis is sus-
pected. Surgical treatment is indicated for significant
underlying sinus disease or SPA [8].is distributed under the terms of the Creative Commons Attribution 4.0
rg/licenses/by/4.0/), which permits unrestricted use, distribution, and
e appropriate credit to the original author(s) and the source, provide a link to
changes were made.
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One-hundred two patients were included, 66 males
(64.7%) and 36 females (35.3%). The mean age was
25.56 years + 18.87 (range 2 to 70 years). There were 52
adults and 50 children. All of them had unilateral orbital
affection.
As regards the etiology of orbital cellulitis, 66 patients
(64.7%) had radiological evidence of paranasal sinusitis
(Fig. 1a), 36 patients had ethmoidal sinusitis, 6 patients
had frontal sinusitis, and 24 patients had multiple si-
nuses affection, two of them had fungal orbital cellulitis
(mucormycosis). Orbital trauma was the cause in 14 pa-
tients (13.7%), with 12 patients having penetrating
trauma, two of them had a retained wood intraorbital
foreign body while orbital cellulitis in 2 patients was
secondary to blunt trauma with surgical emphysema of
the orbit (Fig. 1b). In six patients (5.9%), orbital cellulitis
was a complication of panophthalmitis secondary to
extension of infection from the globe. Two patients (2%)
developed orbital cellulitis due to dental infection in the
form of dental abscess in one patient and complicated
dental surgical procedure in the other (Fig. 1c). No
definite source of infection was identified in 14 patients
(13.7%), and the possibility of hematogenous spread
from distant source was proposed.
Clinically, all patients presented with proptosis, perior-
bital edema, and tenderness with restriction of ocular
motility. Table 1 summarizes the clinical data at the time
of presentation. SPA developed in 16 patients, superiorFig. 1 Etiology of orbital cellulitis. a Sinusitis. b Traumatic.
c Dental infectionSPA in 10 patients, medial in 4 patients, and combined
superior and medial abscesses in 2 patients (Fig. 2). All
cases with SPA had paranasal sinusitis. Fourteen patients
required surgical drainage, and two children with medial
SPA responded to medical treatment.
All patients received medical treatment, and 20 patients
were subjected to surgical interference. Fourteen patients
had surgical drainage of SPA and four patients required
evisceration. Evisceration indicated in patients presenting
with complete loss of vision (no perception of light) with
corneal abscess and no response to medical treatment forFig. 2 Subperiosteal abscess. a Preoperative. b Postoperative
Table 2 Correlation between the duration of hospital admission
and age and surgical interference
Variable Duration of hospital admission
r P value
Agea 0.476 <0.001*
Surgical interferenceb 0.360 0.009*
aPearson’s correlation
bSpearman’s rho correlation
*Significant correlation at P value ≤0.05
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cases of mucormycosis. Histopathology confirmed the
clinical diagnosis. The duration of hospital admission
ranged from 4 to 15 days (mean 6.76 days ± 2.58). A clin-
ically significant positive correlation was found between
the duration of hospital admission and both of the age of
the patient and surgical interference (Fig. 3 and Table 2).
The presenting BCVA ranged from 6/6 to no percep-
tion of light (No PL). Table 3 shows the BCVA at first
presentation and 2 weeks after discharge from hospital
in 96 patients. Six patients were too young to nume-
rically evaluate BCVA. Table 4 shows a comparison
between the presenting and the final BCVA.
There was a clinically significant negative correlation
between the final BCVA and the age of the patient,
RAPD, SPA, surgical interference, and the duration of
hospital admission (Table 5).
Throughout this study, no cases of cavernous sinus
thrombosis or intracranial infection were present. Apart
from patients subjected to orbital exenteration, all pa-
tients had disappearance of active inflammatory signs
with recovery of proptosis and ocular motility restriction
2 weeks after the time of hospital discharge.Discussion
This study examined the clinical presentation and out-
comes of management of cases of orbital cellulitis pre-
sented to Minia University Hospital over a period of
6 years. Minia University Hospital provides medical
emergency and tertiary service for a population of five
million people from nine towns in Upper Egypt.Fig. 3 Correlation between the duration of hospital admission in days (D)In this study, paranasal sinusitis was present in 64.7%
of patients of which ethmoidal sinusitis was present in
35.3%, frontal sinusitis in 5.8%, and pansinusitis in 23.5%
of patients. Reported rates of an associated sinusitis with
orbital cellulitis varied from 15 to 100% [9–13]. In the
current study, orbital trauma was present in 13.7% of
patients. Trauma was the predisposing factor in 19.7% of
patients in the study of Chaudhry et al. and 21.7% of
patients in the study of Hodges and Tabbara [3, 9]. Both
studies were in Saudi Arabia. Trauma was present in
24% of patients of Pandian et al. in South India [12].
With the improvement in management of endophthal-
mitis, fewer cases present with orbital cellulitis second-
ary to endophthalmitis and panophthalmitis. These cases
represent 6% in this study, compared to 17% in older
studies [9].
Clinically, all patients presented with unilateral prop-
tosis, periorbital edema and tenderness, and restriction
of ocular motility. Fever was absent in 39.2% of patients.
This may be due to the prescription of anti-inflammatory
and antipyretic drugs before presenting to the hospital.
SPA developed in 15.68% of patients. The incidence ofand age of the patients in years (Y)
Table 3 Best corrected visual acuity (BCVA) at the first
presentation and at the end of treatment
BCVA Presenting Final P value
BCVA BCVA
(Number = 96) (Number = 96)
No PL 12 (12.5%) 14 (14.6%) <0.001*
≤1/60 2 (2.1%) 0 (0%)
≤6/60 4 (4.2%) 0 (0%)
6/36 2 (2.1%) 0 (0%)
6/24 4 (4.2%) 0 (0%)
6/18 8 (8.3%) 0 (0%)
6/12 26 (27.1%) 8 (8.3%)
6/9 26 (27.1%) 32 (33.3%)
6/6 12 (12.5%) 42 (43.8%)
BCVA best corrected visual acuity, No PL no perception of light
*Significant difference at P value ≤0.05
Table 5 Correlation between the final best corrected visual
acuity and other clinical variables




Hospital stay −0.519 <0.001*
RAPD −0.558 <0.001*
Surgical interference −0.491 <0.001*




Dental affection −0.314 0.018*
Distant infection −0.431 0.002*
Panophthalmitis −0.216 0.140
Penetration eye trauma −0.080 0.587
Trauma + foreign body −0.056 0.704
SPA subperiosteal abscess, RAPD relative afferent pupillary defect
aSpearman’s rho correlation
*Significant correlation at P value ≤0.05
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SPA was reported in the study of Pandian et al. in India
(71 patients), in the reviews from Children’s Memorial
Hospital in Chicago (87 patients) and Children’s Hospital
in Pittsburgh (104 patients) [12, 14, 15]. However, CT scan
was done in only 20 patients in the first study; therefore,
SPA could be easily missed. Fanella et al. studied the
epidemiology and clinical data of pediatric orbital cellulitis
in Manitoba. They identified 38 patients with orbital cellu-
litis. SPA occurred in 31.5% of patients [11]. According to
Lee and Yen, frequent locations for the development of
SPA include the medial orbital wall and the orbital floor
due to the thin medial wall adjacent to the ethmoid sinus
and the thin orbital floor above the maxillary sinus,
respectively [16]. However, in the present study, superior
SPA occurred in 62.5%, medial in 25%, and combined
superior and medial abscesses in 12.5% of patients with
SPA. No abscess related to orbital floor was detected. Su-
perior SPA was present in four cases with isolated
ethmoidal sinusitis with no frontal sinus affection.
The higher frequency of superior SPA in this study, in
spite of the more frequent ethmoidal sinusitis, could be
explained by the relatively easier separation of the peri-
orbita from the orbital roof. The periorbita is firmly
attached at the suture lines, the foramina, and the arcusTable 4 The overall visual outcome at the end of treatment
Visual outcome Ranks Number




BCVA best corrected visual acuity
aFinal BCVA < presenting BCVA
bFinal BCVA > presenting BCVA
cFinal BCVA = presenting BCVAmarginalis. Elsewhere, it is loosely adherent and may be
easily separated from the bone. The orbital aspect of the
roof is generally smooth and presents only one suture
between the frontal and sphenoid bone and this suture
becomes obliterated with age. On the other hand, the
medial wall is formed from parts of four bones with
vertical sutures between them. Moreover, the posterior
and anterior ethmoidal foramina which can permit
transfer of infection from ethmoidal sinuses to the orbit
open above the frontoethmoid suture being more related
to the orbital roof [17].
Hospital admission and IV antibiotics are essential in
management of orbital cellulitis. Many antibiotic combi-
nations were used in different studies. Pandian et al. used
a combination of IV penicillin and gentamicin in all pa-
tients. They used cephalosporins, vancomycin, and other
antibiotics based on the sensitivity pattern or absence of
clinical improvement with initial treatment [12].
Fanella et al. used different combinations of IV cefurox-
ime, clindamycin, cephalosporin, cloxacillin, cefotaxime,
vancomycin, metronidazole, penicillin, and ampicillin.
They changed initial antibiotics in 32% of cases based on
infectious diseases consultations [11].
According to Lee and Yen, local trends in antimicro-
bial susceptibility are critically important considerations
in orbital cellulitis treatment as different communities
have distinctive flora and varied resistance profiles [16].
In this study, a combination of intravenous vanco-
mycin and ceftazidime was used. Vancomycin covers S.
pneumoniae and other streptococci, methicillin-resistant
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forming anaerobes while ceftazidime covers Pseudo-
monas spp.; H. influenzae, Klebsiella spp.; Enterobacter
spp.; Proteus; Escherichia coli; Serratia spp.; Citrobacter
spp.; S. pneumoniae; methicillin-susceptible S. aureus;
and Streptococcus pyogenes (group A beta-hemolytic
streptococci). Antibiotic modification was done in cases
with lack of clinical improvement or according to
culture sensitivity in surgically treated patients.
The use of corticosteroids in the treatment of orbital
cellulitis is controversial. The possibility of suppression
of the immune system and worsening of the disease
process should be considered. However, when used
under the coverage of appropriate antibiotics, the use of
systemic steroids decrease the inflammatory response
and does not appear to adversely affect the outcome
[18]. In this study, systemic steroids were used in cases
with severe edema, marked drop of vision, or RAPD.
Once SPA develops, rapidly progressive visual and
intracranial complications may occur. Therefore, the
prompt surgical drainage when an abscess is first diagnosed
by CT scan should be considered. Medical treatment alone
may be sufficient in younger patients [6, 19–21]. Medial or
inferior SPA is more likely to respond to medical therapy,
while superior SPA requires surgical drainage [22]. In
this study, 87.5% of patients with SPA required surgi-
cal drainage and only two children (12.5%) with small
medial SPA were treated medically.
The duration of hospital admission was longer in
patients subjected to surgical intervention and older
patients who had less response to treatment.
The final visual outcome of the patients in this study
revealed visual improvement in 58% and visual deterior-
ation in 4% of cases. Thirty-eight percent of patients had
unchanged BCVA. Factors adversely affected the final
BCVA including the patient age, RAPD, and SPA. Six
patients presented late with complete visual loss in the
affected eye (No PL) and had no visual improvement at
the end of treatment, and only one patient with SPA lost
his vision due to optic atrophy after late presentation
and delayed surgical interference.
Pandian et al. in South India reported improved visual
outcome in 60% of 33 patients with orbital cellulitis. The
causes for poor outcomes in their study were panoph-
thalmitis (two cases), perforated scleral abscess (one
case), phthisis bulbi (two cases), choroiditis (two cases),
orbital abscess (four cases), and retinal detachment (one
case). The first three patients were treated with eviscer-
ation. Six patients lost vision due to these complications
[12]. Ferguson and McNab studied treatment outcomes
in 52 patients with orbital cellulitis in Melbourne. They
had only one patient who lost his vision due to enucle-
ation for endophthalmitis that had caused orbital cellu-
litis and one patient who developed meningitis [2].Hartstein et al. reported three patients with SPA who
developed intracranial abscess [23]. No intracranial in-
volvement was detected in the current study.
Conclusion
Favorable outcomes in orbital cellulitis are associated
with good presenting visual acuity and appropriate med-
ical treatment together with early surgical intervention
in cases of SPA. All cases with SPA had paranasal sinus-
itis, and contrary to previous studies, superior SPA loca-
tion was the most common followed by the medial
location.
Methods
The study included 102 patients diagnosed to have
orbital cellulitis and were treated in the Ophthalmology
Department of Minia University Hospital from July 2009
to July 2015.
All patients were admitted to the hospital and treated
on inpatient basis. All patients were subjected to oph-
thalmological evaluation, systemic evaluation, and ear,
nose, and throat (ENT) consultation. Ophthalmological
evaluation included history taking, orbital, and ocular
examination. Orbital examination included inspection,
palpation, and exophthalmometry. Ocular examination
included slitlamp examination, pupillary reaction testing,
ocular motility assessment, best corrected visual acuity
(BCVA) recording, intraocular pressure measurement,
and fundus examination. Axial and coronal orbital CT
scans and orbital echography were done for all patients.
All patients received medical treatments, and 20 patients
needed surgical intervention.
Treatment protocol
All patients received parenteral broad-spectrum antibi-
otics covering gram-positive, gram-negative, and anaer-
obic bacteria in the form of a combination of IV
vancomycin and ceftazidime. IV clindamycin was added
in 12 patients and oral metronidazole in 8 patients
according to the response to treatment or culture results
in the surgically treated cases. Oral antibiotic (combin-
ation of amoxicillin and clavulanic acid) was given to all
patients for 2 weeks after discharge from hospital. Top-
ical antibiotic ointment, tear substitutes, and patching
were considered in cases with corneal exposure. Topical
and/or systemic ocular hypotensive drugs were given if
there is associated rise of the intraocular pressure.
Systemic steroids were added in cases with severe
edema, cases presented with drop in the BCVA (≤6/18),
and patients with relative afferent pupillary defect
(RAPD, 42 patients). IV amphotericin B was given to
two cases of fungal orbital cellulitis (mucormycosis).
Surgical intervention was performed in 14 patients
with SPA in the form of surgical drainage under general
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ation was done in four cases presented with panophthal-
mitis and complete loss of vision (no perception of light)
with no response to medical treatment. Orbital exenter-
ation with surgical debridement of the necrotic tissues
was done in two cases of mucormycosis in collaboration
with ENT and maxillofacial surgeons.
This study was approved by the local ethics committee
of Minia University and was adhered to the tenets of the
Declaration of Helsinki. Informed consent was obtained
from each patient after explanation of the nature and
possible consequences of the study.
Statistical method
The patient demographics, etiology, the visual acuity,
the frequency of the development of SPA, the duration
of hospital admission, the rate, and outcomes of surgical
intervention were statistically analyzed using SPSS pro-
gram (Statistical Package for Social Sciences) software
version 20. Analyses were done for qualitative variables
at different times using the Wilcoxon signed-rank test.
Correlation between two quantitative variables was done
using Pearson’s correlation coefficient, while correlation
between qualitative ordinal variables was done using
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